Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1969 Jan;35(1):175–186. doi: 10.1111/j.1476-5381.1969.tb07978.x

The pharmacology of a new oxytocic principle from ox hypothalamus

R W Hawker, W G North, B Zerner
PMCID: PMC1703089  PMID: 5812485

Abstract

1. An oxytocic substance has been isolated from ox hypothalamus by successive gel filtration on Sephadex G-25 and Sephadex G-50, and its pharmacology has been examined on three smooth muscle preparations.

2. The substance has the same order of potency on rat uterus, guinea-pig ileum, and hen rectal caecum.

3. The action of the substance on rat uterus was not abolished by thioglycollate.

4. Atropine (1.0 μg/ml.), phenoxybenzamine (0.1 μg/ml.) and mepyramine (1.0 μg/ml.) did not block the smooth muscle action of the substance.

5. Drug action, relative potency, and log dose-response relationships distinguish the substance from 5-hydroxytryptamine, acetylcholine, oxytocin, vasopressin, angiotensin amide, bradykinin, and purified preparations of substance P.

Full text

PDF
175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BISSET G. W., LEWIS G. P. A spectrum of pharmacological activity in some biologically active peptides. Br J Pharmacol Chemother. 1962 Aug;19:168–182. [PMC free article] [PubMed] [Google Scholar]
  2. CLEUGH J., GADDUM J. H., HOLTON P., LEACH E. Assay of substance P on the fowl rectal caecum. Br J Pharmacol Chemother. 1961 Aug;17:144–158. doi: 10.1111/j.1476-5381.1961.tb01115.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CLEUGH J., GADDUM J. H., MITCHELL A. A., SMITH M. W., WHITTAKER V. P. SUBSTANCE P IN BRAIN EXTRACTS. J Physiol. 1964 Jan;170:69–85. doi: 10.1113/jphysiol.1964.sp007314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HAWKER R. W., BLACKSHAW J. K., ROBERTS V. S., GOODRICKE B. Oxytocic activity of kitten hypothalamic extracts. Med J Aust. 1962 Oct 20;49(2):621–624. [PubMed] [Google Scholar]
  5. LEDERIS K. Vasopressin and oxytocin in the mammalian hypothalamus. Gen Comp Endocrinol. 1961 Apr;1:80–89. doi: 10.1016/0016-6480(61)90027-2. [DOI] [PubMed] [Google Scholar]
  6. MUNSICK R. A. Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogues. Endocrinology. 1960 Mar;6:451–457. doi: 10.1210/endo-66-3-451. [DOI] [PubMed] [Google Scholar]
  7. North W. G., Hawker R. W., Zerner B. Isolation of new oxytocic substance from ox hypothalamus. Biochim Biophys Acta. 1968 Jun 26;160(2):286–288. doi: 10.1016/0005-2795(68)90107-4. [DOI] [PubMed] [Google Scholar]
  8. SAWYER W. H. Neurophypophysial hormones. Pharmacol Rev. 1961 Jun;13:225–277. [PubMed] [Google Scholar]
  9. Valtin H., Sawyer W. H., Sokol H. W. Neurohypophysial principles in rats homozygous and heterozygous for hypothalamic diabetes insipidus (Brattleboro strain). Endocrinology. 1965 Oct;77(4):701–706. doi: 10.1210/endo-77-4-701. [DOI] [PubMed] [Google Scholar]
  10. ZETLER G. New pharmacologically active polypeptides present in impure preparations of substance P. Ann N Y Acad Sci. 1963 Feb 4;104:416–436. doi: 10.1111/j.1749-6632.1963.tb17686.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES